stella
beta
Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC — Stella
Recruiting
Back to Recurrent or Metastatic Nasopharyngeal Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Fifth affiliated hosptial of Sun-yat Sen university, Zhuhai, Guangzhou
View full record on ClinicalTrials.gov